financetom
Business
financetom
/
Business
/
Taysha Gene Therapies Insider Bought Shares Worth $2,062,500, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taysha Gene Therapies Insider Bought Shares Worth $2,062,500, According to a Recent SEC Filing
Jun 4, 2025 1:10 AM

03:48 AM EDT, 06/04/2025 (MT Newswires) -- Paul B Manning, 10% Owner, on May 30, 2025, executed a purchase for 750,000 shares in Taysha Gene Therapies ( TSHA ) for $2,062,500. Following the Form 4 filing with the SEC, Manning has control over a total of 25,601,111 common shares of the company, with 25,601,111 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1806310/000141588925015480/xslF345X05/form4-06042025_010624.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved